Insider Transactions in Q1 2023 at Medifast Inc (MED)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2023
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
906
+37.72%
|
-
|
|
Mar 17
2023
|
James P. Maloney Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,574
+38.46%
|
-
|
|
Mar 17
2023
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
75
-2.66%
|
$7,650
$102.75 P/Share
|
|
Mar 17
2023
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
16,807
+26.29%
|
-
|
|
Mar 17
2023
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
872
-2.8%
|
$88,944
$102.75 P/Share
|
|
Mar 16
2023
|
Jonathan Barrett Mac Kenzie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
57
-8.81%
|
$5,928
$104.46 P/Share
|
|
Mar 16
2023
|
James P. Maloney Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
123
-4.18%
|
$12,792
$104.46 P/Share
|
|
Mar 16
2023
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,358
-4.17%
|
$141,232
$104.46 P/Share
|
|
Mar 10
2023
|
Scott Schlackman Director |
SELL
Open market or private sale
|
Direct |
2,200
-23.21%
|
$237,600
$108.68 P/Share
|
|
Mar 10
2023
|
Scott Schlackman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+18.84%
|
$59,400
$27.68 P/Share
|
|
Feb 24
2023
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,643
-32.46%
|
$1,705,087
$109.99 P/Share
|
|
Feb 24
2023
|
Daniel R Chard Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,076
+41.42%
|
-
|
|
Feb 21
2023
|
Daniel R Chard Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,815
-11.39%
|
$208,725
$115.31 P/Share
|
|
Feb 07
2023
|
Michael A. Hoer Director |
BUY
Open market or private purchase
|
Direct |
9
+0.17%
|
$1,026
$114.97 P/Share
|
|
Feb 07
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Direct |
11
+0.46%
|
$1,254
$114.97 P/Share
|
|
Feb 07
2023
|
Constance J. Hallquist |
BUY
Open market or private purchase
|
Direct |
9
+0.12%
|
$1,026
$114.97 P/Share
|
|
Feb 07
2023
|
Scott Schlackman Director |
BUY
Open market or private purchase
|
Direct |
9
+0.12%
|
$1,026
$114.97 P/Share
|
|
Feb 07
2023
|
Andrea B Thomas Director |
BUY
Open market or private purchase
|
Direct |
9
+0.3%
|
$1,026
$114.97 P/Share
|
|
Feb 03
2023
|
Jeffrey J Brown Director |
BUY
Open market or private purchase
|
Indirect |
570
+1.37%
|
$66,120
$116.11 P/Share
|